Smith & Nephew, INC.

Based in DC

🤖

AI Overview

With $14.1M in lobbying spend across 33 quarterly filings, Smith & Nephew, INC is one of the biggest lobbying spenders in Washington. Their lobbying covers 10 issue areas. Active from 2018 to 2025.

$14.1M
Total Spend
8
Years Active
1
Firms Hired
5
Lobbyists Deployed
10
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$1.9M
2019$1.9M
2020$1.7M
2021$1.7M
2022$1.6M
2023$1.7M
2024$2.2M
2025$1.5M

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Smith & Nephew, INC. disclosed contacting in their lobbying filings.

Commerce, Dept of (DOC)HOUSE OF REPRESENTATIVESSENATEU.S. Trade Representative (USTR)Centers For Medicare and Medicaid Services (CMS)Treasury, Dept ofExecutive Office of the President (EOP)Natl Economic Council (NEC)Health & Human Services, Dept of (HHS)Office of Management & Budget (OMB)State, Dept of (DOS)White House OfficeFood & Drug Administration (FDA)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Government Issues, Trade, Taxation, Health Issues and 5 more

Medicare Part D reimbursement proposals.

H.R. 4170 and S. 2039, Disclosing Foreign Influence Act.

S. 2482, Foreign Agents Registration Amendments Act.

Issues related to market access for medical devices in India.

H.R. 184, Protect Medical Innovation Act of 2017.

S. 108, Medical Device Access & Innovation Protection Act.

Implementation of H.R. 1, Tax Cuts and Jobs Act.

H.R. 195, Making further continuing approp

Issues related to post-market surveillance of medical devices and unique device identifiers.

Issues related to third-party servicing of medical devices.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.